5-((3aS,4S,6aR)-1,3-Dibenzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid
              
            
            
              
                
                  
                    | Product Name | 5-((3aS,4S,6aR)-1,3-Dibenzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid | 
                  
                    | Product Code | DA-B139-05 | 
                  
                  
                    | Chemical name | 5-((3aS,4S,6aR)-1,3-Dibenzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid | 
                  
                    | Synonyms | [3aS-(3aa,4B,6aa)]-Hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-thieno[3,4-d]imidazole-4-pentanoic Acid; | 
                  
                    | Impurity | NA | 
                  
                    | CAS Number | 33607-60-2 | 
                  
                    | Alternate CAS # | NA | 
                  
                    | Molecular form | C24H28N2O3S | 
                  
                    | Appearance | NA | 
                  
                    | Melting Point | NA | 
                  
                    | Mol. Weight | 424.56 | 
                  
                    | Storage | 2-8°C Refrigerator | 
                  
                    | Solubility | NA | 
                  
                    | Stability | NA | 
                  
                    | Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals | 
                  
                    | Boiling Point | NA | 
                  
                    | Applications | cis-(-)-1,3-Dibenzylhexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric Acid is an protected intermediate in the synthesis of biotin derivatives. | 
                  
                    | Dangerous Goods Info | NA | 
                  
                    | References | NA | 
                  
                    | Extra Notes | NA | 
                  
                    | Documents (MSDS) | No Data Available | 
                  
                    | Keywords | NA |